Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
IsraelIPO:
26 June 2020Website:
http://www.polypid.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:57:57 GMTDividend
Analysts recommendations
Institutional Ownership
PYPD Latest News
PETACH TIKVA, Israel, June 10, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a virtual Key Opinion Leader (KOL) event on Monday, June 17, 2024, at 10:00 AM ET, to discuss the significant unmet medical need in surgical site infections and provide an update on the Company's ongoing D-PLEX100 Phase 3 trial. To register, click here .
PolyPid Ltd. (PYPD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript
PolyPid Ltd. (NASDAQ:PYPD ) Q3 2023 Earnings Conference Call November 11, 2023 8:00 AM ET Company Participants Dikla Czaczkes Akselbrad - Chief Executive Officer Jonny Missulawin - Chief Financial Officer Ori Warshavsky - Chief Operating Officer Conference Call Participants Roy Buchanan - JMP Raghuram Selvaraju - H.C.
PolyPid Ltd (NASDAQ:PYPD ) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors Dikla Akselbrad - CEO & Director Jonny Missulawin - CFO Ori Warshavsky - COO Conference Call Participants Douglas Buchanan - JMP Securities Operator Greetings, and welcome to the PolyPid Second Quarter 2023 Conference Call. [Operator Instructions].
What type of business is PolyPid?
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
What sector is PolyPid in?
PolyPid is in the Healthcare sector
What industry is PolyPid in?
PolyPid is in the Biotechnology industry
What country is PolyPid from?
PolyPid is headquartered in Israel
When did PolyPid go public?
PolyPid initial public offering (IPO) was on 26 June 2020
What is PolyPid website?
https://www.polypid.com
Is PolyPid in the S&P 500?
No, PolyPid is not included in the S&P 500 index
Is PolyPid in the NASDAQ 100?
No, PolyPid is not included in the NASDAQ 100 index
Is PolyPid in the Dow Jones?
No, PolyPid is not included in the Dow Jones index
When does PolyPid report earnings?
The next expected earnings date for PolyPid is 09 August 2024